Related Experiment Video

Updated: Jun 17, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.6K

PPM1F regulates ovarian cancer progression by affecting the dephosphorylation of ITGB1

Yahui Leng1,2,3,4, Zhenzi Luan1,2,3,4, Zihang Li1,2,3,4

  • 1School of Basic Medicine, Hubei University of Medicine, Shiyan, Hubei, China.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
|August 12, 2024
PubMed

Insights

Protein phosphatase PPM1F and integrin ITGB1 promote ovarian cancer. PPM1F dephosphorylates ITGB1, inhibiting its oncogenic activity and impacting ovarian cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Protein phosphatase PPM1F (PPM1F) has known roles in various cancers.
  • Integrin beta-1 (ITGB1) regulates cell adhesion and migration, crucial in cancer progression.
  • The specific roles of PPM1F and ITGB1 in ovarian cancer remain largely uncharacterized.

Purpose of the Study:

  • To investigate the function and underlying mechanisms of PPM1F in ovarian cancer.
  • To determine the regulatory relationship between PPM1F and ITGB1 in ovarian cancer progression.

Main Methods:

  • Bioinformatic analysis of PPM1F expression and survival data.
  • In vitro gain- and loss-of-function studies for PPM1F and ITGB1.
  • In vivo tumor formation assays in nude mice.
  • Co-immunoprecipitation and Western blotting to assess ITGB1 phosphorylation.
  • Rescue assays to validate functional interactions.

Main Results:

  • PPM1F exhibits oncogenic functions in ovarian cancer.
  • Knockdown of PPM1F significantly inhibited tumor formation in vivo.
  • PPM1F dephosphorylates ITGB1 at T788/T789, modulating integrin activity.
  • Overexpression of a mutated ITGB1 (ITGB1-mut) promoted ovarian cancer progression.
  • PPM1F-mediated dephosphorylation of wild-type ITGB1 (ITGB1-wt) attenuated its oncogenic effects.

Conclusions:

  • PPM1F and ITGB1 function as oncogenes in ovarian cancer.
  • PPM1F regulates ovarian cancer progression through the dephosphorylation of ITGB1.
  • Targeting the PPM1F-ITGB1 axis may offer a therapeutic strategy for ovarian cancer.
Keywords:
DephosphorylationITGB1Ovarian cancerPPM1F

More Related Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.7K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.2K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
323